EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuromuscular disease genetics in under-represented populations: increasing data diversity

Lindsay A Wilson iD, William L Macken iD, Luke D Perry, Christopher J Record iD, Katherine R Schon iD, Rodrigo S S Frezatti iD, Sharika Raga iD, Kireshnee Naidu iD, Özlem Yayıcı Köken, Ipek Polat, Musambo M Kapapa, Natalia Dominik und 48 weitere

Brain · 01.12.2023 · 146 (12) · 5098-5109

DOI: 10.1093/brain/awad254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 30.07.2023. Verfasst von Lindsay A Wilson und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London WC1N 3…. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Neuromuscular Diseases, Muscular Dystrophies, Muscular Dystrophies, Limb-Girdle. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Alzheimer's Society, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuromuscular diseases (NMDs) affect ∼15 million people globally. In high income settings DNA-based diagnosis has transformed care pathways and led to gene-specific therapies. However, most affected families are in low-to-middle income countries (LMICs) with limited access to DNA-based diagnosis. Most (86%) published genetic data is derived from European ancestry. This marked genetic data inequality hampers understanding of genetic diversity and hinders accurate genetic diagnosis in all income settings. We developed a cloud-based transcontinental partnership to build diverse, deeply-phenotyped and genetically characterized cohorts to improve genetic architecture knowledge, and potentially advance diagnosis and clinical management. We connected 18 centres in Brazil, India, South Africa, Turkey, Zambia, Netherlands and the UK. We co-developed a cloud-based data solution and trained 17 international neurology fellows in clinical genomic data interpretation. Single gene and whole exome data were analysed via a bespoke bioinformatics pipeline and reviewed alongside clinical and phenotypic data in global webinars to inform genetic outcome decisions. We recruited 6001 participants in the first 43 months. Initial genetic analyses ‘solved’ or ‘possibly solved’ ∼56% probands overall. In-depth genetic data review of the four commonest clinical categories (limb girdle muscular dystrophy, inherited peripheral neuropathies, congenital myopathy/muscular dystrophies and Duchenne/Becker muscular dystrophy) delivered a ∼59% ‘solved’ and ∼13% ‘possibly solved’ outcome. Almost 29% of disease causing variants were novel, increasing diverse pathogenic variant knowledge. Unsolved participants represent a new discovery cohort. The dataset provides a large resource from under-represented populations for genetic and translational research. In conclusion, we established a remote transcontinental partnership to assess genetic architecture of NMDs across diverse populations. It supported DNA-based diagnosis, potentially enabling genetic counselling, care pathways and eligibility for gene-specific trials. Similar virtual partnerships could be adopted by other areas of global genomic neurological practice to reduce genetic data inequality and benefit patients globally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesNeuromuscular DiseasesMuscular DystrophiesMuscular Dystrophies, Limb-GirdleHumansDNA

Stichwörter der Autor:innen

capacity buildingequality and diversitygenomic medicineinherited neuromuscular diseaselow-to-middle income country

Substanzen

DNA

Autor:innen und Institutionen

  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.
  • Institute of Child Health and Centre for Neuromuscular Diseases, Neurosciences Unit, The Dubowitz Neuromuscular Centre, University College London, UCL Great Ormond Street, Great Ormond Street Hospital, London WC1N 3JH,…
  • NIHR Great Ormond Street Hospital Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
  • Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Department of Neurosciences, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

ORCID-Profile: Lindsay A Wilson, William L Macken, Christopher J Record, Katherine R Schon, Rodrigo S S Frezatti, Sharika Raga, Kireshnee Naidu, Stephanie Efthymiou, Heba Morsy, Mahmoud R Fassad, Armand Vorster, Kosha Srivastava, Richard J L F Lemmers, A Semra Hiz, C Nur Semerci Gündüz, Gülay Güleç Ceylan, Karthik B Tallapaka, David R Bearden, Michelle P Kvalsund, Gita M Ramdharry, Yavuz Oktay, Enrico Bugiardini, Franclo Henning, Jo M Wilmshurst, Jeannine M Heckmann

Förderung

  • NINDS NIH HHS
  • Alzheimer's Society
  • Wellcome Trust
  • Medical Research Council
  • National Brain Appeal
  • University College London Global Engagement Funds
  • Guarantors of Brain
  • World Muscle Society

Zitieren

APA

Wilson, L. A., Macken, W. L., Perry, L. D., Record, C. J., Schon, K. R., Frezatti, R. S. S., Raga, S., Naidu, K., Köken, Ö. Y., Polat, I., Kapapa, M. M., Dominik, N., Efthymiou, S., Morsy, H., Nel, M., Fassad, M. R., Gao, F., Patel, K., Schoonen, M., …, & McFarland, R. (2023). Neuromuscular disease genetics in under-represented populations: increasing data diversity. Brain, 146(12), 5098-5109. https://doi.org/10.1093/brain/awad254

Vancouver

Wilson LA, Macken WL, Perry LD, Record CJ, Schon KR, Frezatti RSS, et al. Neuromuscular disease genetics in under-represented populations: increasing data diversity. Brain. 2023;146(12):5098-5109. doi:10.1093/brain/awad254

BibTeX
@article{Wilson2023,
  author = {Wilson, Lindsay A and Macken, William L and Perry, Luke D and Record, Christopher J and Schon, Katherine R and Frezatti, Rodrigo S S and Raga, Sharika and Naidu, Kireshnee and Köken, Özlem Yayıcı and Polat, Ipek and Kapapa, Musambo M and Dominik, Natalia and Efthymiou, Stephanie and Morsy, Heba and Nel, Melissa and Fassad, Mahmoud R and Gao, Fei and Patel, Krutik and Schoonen, Maryke and Bisschoff, Michelle and Vorster, Armand and Jonvik, Hallgeir and Human, Ronel and Lubbe, Elsa and Nonyane, Malebo and Vengalil, Seena and Nashi, Saraswati and Srivastava, Kosha and Lemmers, Richard J L F and Reyaz, Alisha and Mishra, Rinkle and Töpf, Ana and Trainor, Christina I and Steyn, Elizabeth C and Mahungu, Amokelani C and van der Vliet, Patrick J and Ceylan, Ahmet Cevdet and Hiz, A Semra and Çavdarlı, Büşranur and Semerci Gündüz, C Nur and Ceylan, Gülay Güleç and Nagappa, Madhu and Tallapaka, Karthik B and Govindaraj, Periyasamy and van der Maarel, Silvère M and Narayanappa, Gayathri and Nandeesh, Bevinahalli N and Wa Somwe, Somwe and Bearden, David R and Kvalsund, Michelle P and Ramdharry, Gita M and Oktay, Yavuz and Yiş, Uluç and Topaloğlu, Haluk and Sarkozy, Anna and Bugiardini, Enrico and Henning, Franclo and Wilmshurst, Jo M and Heckmann, Jeannine M and McFarland, Robert},
  title = {Neuromuscular disease genetics in under-represented populations: increasing data diversity},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {12},
  pages = {5098--5109},
  doi = {10.1093/brain/awad254}
}
Kostenlos starten →